B · Normal
[Baiyunshan: Subsidiary plans to subscribe for HK$350 million in limited partnership shares of the Asia Big Health Fund] On November 16, Baiyunshan (600332.SH) announced that the company’s wholly-owned subsidiary Guangzhou Baiyunshan Hong Kong Co., Ltd. planned to invest HK$350 million in subscribing for the limited partnership share of the Wobo Capital Big Health Limited Partnership Fund (referred to as the “Asia Big Health Fund”), accounting for 35% of its post-raising ratio. The Asia Health Fund plans to be registered in Hong Kong, China, with a target scale of HK$1 billion, focusing on investing in the medical and health industries (including but not limited to the medical health care, life sciences and consumer goods industries).
Comments